Turkey declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 64 of 170 of this archive, newest first.
Efficacy was never the question in this appraisal. Duration of treatment was.
The glucagon arm raises energy expenditure and also raises hepatic glucose output. Balancing those is the whole engineering problem.
Multiple-dose vials are designed for a defined number of punctures. Nobody counts, and the elastomer does not care whether anybody counts.
One omitted dose is a labelling question. Four omitted doses is a clinical one. The two are routinely conflated.
The document is four pages. Three of them are about dates.
Reported from the sessions, and from the two hours afterwards.
Efficacy was never the question in this appraisal. Duration of treatment was.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The Journal submitted split samples from single lots to three assay services, under names unconnected to this publication, and published each method alongside each result.
A proper account of an operation that existed, and of what closing it cost.
The route did not close because of a rule about peptides.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Storage instructions in this market are close to uniform and almost never accompanied by the study that would justify them. Uniformity is a sign of convention, not of…
Why the reason for stopping changes what happens afterwards.
The route did not close because of a rule about peptides.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A reminder that a purity figure is the output of a method, and that methods differ.
Baseline placement under a tailing peak is a judgement call with a direct effect on the area. It is one of the few places where two competent analysts genuinely disagree.
Reduced intake is a plausible mechanism for deficiency. Reduced absorption is not, and the two are conflated in most of the advice.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
Reported from the analysis, not from a warning notice.
Reported from the sessions, and from the two hours afterwards.
Severity in these tables is graded by interference with activity, not by how unpleasant the experience was. Those are different measurements.
What a laboratory can and cannot know about the provenance, storage history and representativeness of what lands on its bench.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The route did not close because of a rule about peptides.
The observation that closes a facility is rarely the dramatic one.
The observation that closes a facility is rarely the dramatic one.